Posted by Michael Wonder on 24 Jul 2018
RFP - supply of recombinant factor VIII, recombinant factor IX and bypassing agents for the treatment of haemophilia
23 July 2018 - PHARMAC invites proposals for the supply of Recombinant Factor VIII, Recombinant Factor IX and bypassing agents (Recombinant Factor VIIa and FEIBA) in New Zealand.
Submissions to PHARMAC are due no later than 5:00 pm on Monday, 20 August 2018.
